Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Quinn, A.
Right arrow Articles by Sercarz, Eli. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, A.
Right arrow Articles by Sercarz, Eli. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 10, 1321-1333, October 2001
© 2001 Japanese Society for Immunology

Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-Ag7-expressing mouse strains

Anthony Quinn, Marco Melo2,3,, Douglas Ethell1, and Eli. E. Sercarz

La Jolla Institute for Allergy and Immunology, Division of Immune Regulation, and
1 Division of Cellular Immunology, 10355 Science Center Drive, San Diego, CA 92121, USA
2 Department of Microbiology and Molecular Genetics, University of California, Los Angeles,CA 90095-1489, USA

Correspondence to: Correspondence to: A. Quinn

I-Ag7 is a unique class II MHC molecule that is clearly associated with autoimmune diabetes in non-obese diabetic (NOD) mice. To determine if I-Ag7 is defective in its ability to deliver tolerogenic signals in vivo, H-2g7 mice were nasally pretreated with antigen, prior to immunization, to induce antigen-specific regulation. Nasally pretreated NOR (H-2g7) and (NON).NOD (H-2g7) congenic mice showed responses similar to those of NON (H-2nb1), BALB/c (H-2d) and B10.PL (H-2u) mice—a reduced recall response and a deviated Th cytokine profile. However, we found that NOD (H-2g7) mice are comparatively resistant to immunological tolerance induced by nasal pretreatment, such that at the usually effective dose no significant reduction was seen in the proliferative recall responses to nominal antigen after immunization. (NOD x BALB/c)F1 (H-2g7/d) and (NOD x NOR)F1 (H-2g7) mice were similarly resistant to nasal-induced tolerance, although significantly higher nasal doses of antigen were able to overcome the resistance in NOD and F1 mice. Interestingly, activated NOD T cells were resistant to cell death induced by re-stimulation with plate-bound anti-CD3. These results demonstrate that activated T cells in NOD mice are defective in their ability to respond to regulatory signals delivered in vivo or in vitro. Furthermore, NOD T cells have an increased resistance to tolerance induced by I-Ag7-dependent (antigen) or I-Ag7-independent (anti-CD3) mechanisms. Thus, while I-Ag7 may contribute to insulin-dependent diabetes mellitus by selecting a particular repertoire of self-reactive T cell clones, additional defects in the peripheral T cells themselves are required to allow the expansion of diabetogenic clones and the development of autoimmune disease.

Keywords: apoptosis, immune deviation, hen egg lysozyme, mucosal, T cells

3 Present address: Department of Immunology, Holland Laboratory, American Red Cross, Rockville, MD 208552, USA

Transmitting editor: G. Doria


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath
Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics
J. Immunol., March 1, 2005; 174(5): 2746 - 2755.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.